Sign in Sign up

Ibsa Pharma Inc FDA Recalls

15 recalls on file across drugs, 0 of them Class I and 0 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product	Reason	Class	Initiated
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for Class IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IClass IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for Class IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IClass IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for Class IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured forClass IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for Class IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IClass IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 25 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IClass IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 125 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured forClass IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IClass IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured forClass IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for Class IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured forClass IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for Class IIJan 30, 2023Subpotent Drug	Subpotent Drug	Class IIDrugs	Jan 30, 2023

Related datasets

FDA ApprovalsNew drugs approved, and devices cleared for sale.Workplace SafetyOSHA inspections and citations, by company.Congress TradingThe live feed of disclosed transactions.Politician SearchEvery member who files, and what they hold.